期刊文献+

含玻璃酸钠的复方硫酸软骨素滴眼液中硫酸软骨素的含量测定 被引量:3

Determination of chondroitin sulfate in compound chondroitin sulfate eye drops containing sodium hyaluronate
下载PDF
导出
摘要 目的建立含玻璃酸钠(SH)的复方硫酸软骨素滴眼液中硫酸软骨素(CS)的含量测定方法。方法通过醋酸钠调节样品的酸碱度和离子强度,氯化十六烷基吡啶(CPC)可选择性地沉淀CS,采用咔唑法测定CS的含量,而不受SH的影响。结果优化的样品预处理条件为:醋酸钠的浓度为16%,CPC的浓度为0.8%,充分搅拌后,静置2 h,20μm滤膜过滤;滤饼经8%氯化钠溶液超声解离后,用于CS的含量测定,回收率为100.2%,RSD为1.17%。结论此法简便,快速,结果准确,可作为含SH的复方硫酸软骨素滴眼液中CS的含量测定方法。 Purpose To establish a method tor determining the content of chondroitin sulfate(CS)in compound chondroitin sulfate eye drops containing sodium hyaluronate (SH). Methods A carbazole method was used for determining the content of CS. By regulating acidity or alkalinity and ionic strength with sodium acetate, CS was selectively precipitated with cetylpyridinium chloride(CPC), whereas SH was not. Results Optimal samples pretreatment conditions were as follows:The mass concentrations of sodium acetate and CPC were 16% and 0.8%, respectively, and they were stirred thoroughly, standing for 2 h, and filtered by 20μm film. The method recovery was 100.2%with RSD of 1.17%. Conclusion The method is simple, rapid and accurate. It can be used for determining the content of CS in compound ehondroitin sulfate eye drops containing SH.
出处 《中国生化药物杂志》 CAS CSCD 北大核心 2009年第1期43-45,共3页 Chinese Journal of Biochemical Pharmaceutics
关键词 复方硫酸软骨素滴眼液 玻璃酸钠 咔唑法 含量测定 compound ehondroitin sulfate eye drops sodium hyaluronate carbazole method determination
  • 相关文献

参考文献6

二级参考文献46

  • 1林国平,李斌元,戴春秀.硫酸软骨素生产工艺的改进[J].中国生化药物杂志,2005,26(1):43-44. 被引量:7
  • 2晏晓明.关注滴眼剂的眼表毒性[J].中华眼科杂志,2005,41(5):387-389. 被引量:69
  • 3谢营樑.软骨鱼类资源开发现状及发展前景[J].现代渔业信息,1996,11(6):17-20. 被引量:7
  • 4傅应华.鲨鱼硫酸软骨素中蛋白质比色法定量的方法学研究[J].中国生化药物杂志,2006,27(5):294-296. 被引量:1
  • 5Matsumoto Y,Yamamoto I,Watanabe Y,et al.Enhancing effect of viscous sodium hyaluronate solution on the rectal absorption of morphine[J].Biol Pharm Bull,1995,18(12):1744-1749.
  • 6Morimoto K,Yamaguchi H,Iwakura Y,et al.Effects of viscous hyaluronate-sodium solutions on the nasal absorption of vasopressin and an analogue[J].Pharm Res,1991,8(4):471-474.
  • 7Morimoto K,Metsugi K,Katsumata H,et al.Effects of low-viscosity sodium hyaluronate preparation on the pulmonary absorption of rh-insulin in rats[J].Drug Dev Ind Pharm,2001,27(4):365-371.
  • 8Sandri G,Rossi S,Ferrari F,et al.Mucoadhesive and penetration enhancement properties of three grades of hyaluronic acid using porcine buccal and vaginal tissue,Caeo-2 cell lines,and rat jejunum [J].J Pharm Pharmacol,2004,56 (9):1083-1090.
  • 9Brown TJ,Hatherell EM,Falzon JL,et al.Hyaluronan targeting of antimetabolite anti-cancer drugs to human breast tumor xenografts [Z].(2005) Submitted to Cancer Chemother Pharmacol.
  • 10Rosenthal MA,Gibbs P,Brown TJ,et al.Phase I and pharmacokinetic evaluation of intravenous hyaluronic acid in combination with doxorubicin or 5-fluorouracil [J].Chemotherapy,2005,51 (2-3):132-141.

共引文献32

同被引文献44

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部